These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11413727)

  • 1. Five-year experience with implantation and follow-up of transvenous implantable cardioverter defibrillators: placing postimplant defibrillation threshold testing in perspective.
    Roman-Gonzalez J; Shapiro ML; Rubal BJ; Bulgrin JR; Muse RJ
    Mil Med; 2001 Jun; 166(6):500-4. PubMed ID: 11413727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The subcutaneous array: a new lead adjunct for the transvenous ICD to lower defibrillation thresholds.
    Higgins SL; Alexander DC; Kuypers CJ; Brewster SA
    Pacing Clin Electrophysiol; 1995 Aug; 18(8):1540-8. PubMed ID: 7479175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of routine follow-up defibrillator threshold testing in congenital heart disease and pediatric populations.
    Stephenson EA; Cecchin F; Walsh EP; Berul CI
    J Cardiovasc Electrophysiol; 2005 Jan; 16(1):69-73. PubMed ID: 15673391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is ICD-programming for double intraoperative defibrillation threshold energy safe and effective during long-time follow-up? Results of a prospective randomized multicenter study (Low-Energy Endotak Trial--LEET)].
    Himmrich E; Liebrich A; Michel U; Neuzner J; Pitschner H; Heisel A; Vester E; Ganschov U; Jung J
    Z Kardiol; 1999 Feb; 88(2):103-12. PubMed ID: 10209831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative defibrillation threshold testing during implantable cardioverter-defibrillator insertion: do we really need it?
    Calvi V; Dugo D; Capodanno D; Arancio R; Di Grazia A; Liotta C; Puzzangara E; Ragusa A; Arestia A; Tamburino C
    Am Heart J; 2010 Jan; 159(1):98-102. PubMed ID: 20102873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reproducibility of the effectiveness of defibrillation for terminating induced ventricular fibrillation using intraoperatively measured defibrillation threshold energy in patients with implanted cardioverter-defibrillator].
    Jung J; Neuzner J; Himmrich E; Vester E; Michel U; Fries R; Pitschner H; Liebrich A; Ganschow U; Heisel A
    Z Kardiol; 1998 Dec; 87(12):971-7. PubMed ID: 10025070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of an active abdominal pulse generator on defibrillation thresholds with a dual-coil, transvenous ICD lead system.
    Rashba EJ; Farasat M; Kirk MM; Shorofsky SR; Peters RW; Gold MR
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):617-20. PubMed ID: 16836709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Implantable cardioverter/defibrillator: long-term stability of the defibrillation threshold with a unipolar electrode configuration (active-can")].
    Knuefermann P; Wolpert C; Spehl S; Korte T; Manz M; Lüderitz B; Jung W
    Z Kardiol; 2000 Sep; 89(9):774-80. PubMed ID: 11077687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological laboratory, electrophysiologist-implanted, nonthoracotomy-implantable cardioverter/defibrillators.
    Fitzpatrick AP; Lesh MD; Epstein LM; Lee RJ; Siu A; Merrick S; Griffin JC; Scheinman MM
    Circulation; 1994 Jun; 89(6):2503-8. PubMed ID: 8205656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience.
    Weinstock J; Bader YH; Maron MS; Rowin EJ; Link MS
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Efficacy and Necessity of Routine Defibrillation Threshold Testing in Patients Undergoing Implantable Cardioverter-Defibrillator (ICD) Implantation.
    Ashino S; Nakai T; Sonoda K; Sasaki N; Kurokawa S; Ikeya Y; Okumura Y; Ohkubo K; Kunimoto S; Watanabe I; Hirayama A
    Int Heart J; 2015; 56(6):618-21. PubMed ID: 26549282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of defibrillation efficacy using implantable cardioverter-defibrillator with single- or dual-coil defibrillation leads and active can.
    Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Raczak G; Swiatecka G
    Kardiol Pol; 2005 Sep; 63(3):234-41; discussion 242-3. PubMed ID: 16180177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety margins: lessons from the Low Energy Endotak Trial (LEET).
    Neuzner J
    Am J Cardiol; 1996 Sep; 78(5A):26-32. PubMed ID: 8820833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defibrillation threshold testing: is it necessary during implantable cardioverter-defibrillator implantation?
    Liu QM; Bai ZL; Liu ZJ; Li XP; Zhou SH
    Med Hypotheses; 2009 Feb; 72(2):147-9. PubMed ID: 18980811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of very high defibrillation thresholds (DFT) and efficacy of subcutaneous (SQ) array insertion during implantable cardioverter defibrillator (ICD) implantation.
    Verma A; Kaplan AJ; Sarak B; Oosthuizen R; Beardsall M; Higgenbottam J; Wulffhart Z; Khaykin Y
    J Interv Card Electrophysiol; 2010 Nov; 29(2):127-33. PubMed ID: 20865309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and temporal stability of reduced safety margins for ventricular defibrillation: primary results from the Low Energy Safety Study (LESS).
    Gold MR; Higgins S; Klein R; Gilliam FR; Kopelman H; Hessen S; Payne J; Strickberger SA; Breiter D; Hahn S
    Circulation; 2002 Apr; 105(17):2043-8. PubMed ID: 11980683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of defibrillation threshold testing during implantable cardioverter-defibrillator placement: data from the Israeli ICD Registry.
    Arnson Y; Suleiman M; Glikson M; Sela R; Geist M; Amit G; Schliamser JE; Goldenberg I; Ben-Zvi S; Orvin K; Rosenheck S; Adam Freedberg N; Strasberg B; Haim M
    Heart Rhythm; 2014 May; 11(5):814-21. PubMed ID: 24486799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High defibrillation thresholds in transvenous biphasic implantable defibrillators: clinical predictors and prognostic implications.
    Shukla HH; Flaker GC; Jayam V; Roberts D
    Pacing Clin Electrophysiol; 2003 Jan; 26(1 Pt 1):44-8. PubMed ID: 12685138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiologist-implanted transvenous cardioverter defibrillators using local versus general anesthesia.
    Manolis AS; Maounis T; Vassilikos V; Chiladakis J; Cokkinos DV
    Pacing Clin Electrophysiol; 2000 Jan; 23(1):96-105. PubMed ID: 10666758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.